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ScienceDirectMetastasis begins with the invasion of tumor cells into the stroma
and migration toward the blood stream. Human pathology
studies suggest that tumor cells invade collectively as strands,
cords and clusters of cells into the stroma, which is dramatically
reorganized during cancer progression. Cancer cells in intravital
mouse models and in vitro display many ‘modes’ of migration,
from single isolated cells with round or elongated phenotypes to
loosely-/non-adherent ‘streams’ of cells or collective migration
of cell strands and sheets. The tumor microenvironment, and in
particular stroma organization, influences the mode and
dynamics of invasion. Future studies will clarify how the
combination of stromal network structure, tumor cell signaling
and extracellular signaling cues influence cancer cell migration
and metastasis.
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Introduction
Metastasis is a hallmark of cancer and the leading cause of
mortality among cancer patients [1]. Cancer, in its most
virulent form, is thus not only a disease of uncontrolled cell
growth, but also a disease of uncontrolled cell migration.
The first step in metastasis is the migration of cancer cells
away from the primary tumor, a process called tumor
invasion (Figure 1). In solid epithelial tumors, or carcinomas,
invading cells must first cross the basement membrane
(BM). The BM is a natural barrier between the epithelium
and the stroma, a network of extracellular matrix (ECM)
populated by a number of other cell types that surrounds
the tissue. Metastasizing cells migrate through the stroma
to reach blood or lymph vessels, where they can be carried
to other organs. In this review, we will focus on the
migration of cancer cells through the stroma. The mecha-
nisms of BM invasion have recently been reviewed [2].www.sciencedirect.com We will first discuss general features of cancer cell migra-
tion through the stroma, with a focus on tumor cell
morphology and migration mode. Next, we will summa-
rize findings specifically from human pathology studies, in
vivo studies employing intravital imaging techniques, and
in vitro systems, highlighting tumor–stroma interactions.
Finally, we draw attention to the similarities and differ-
ences in findings using these different systems and dis-
cuss outstanding questions in the field.
Modes of cancer cell migration
Both human pathology studies and intravital imaging
studies in mouse systems have revealed a great diversity
in the morphologies of invading cancer cells and the way
these cells migrate. Cancer cells possess a unique ability
to adapt to different environmental conditions, assuming
different morphologies and migration characteristics in
order to stay motile [3]. In vivo, motile tumor cells have
been observed to migrate individually as single cells, as
loosely-attached cell streams and as well-organized,
adherent collectives. In human cancer pathology studies,
cancer cells from epithelial tumors primarily invade col-
lectively, while in intravital imaging studies, cancer cells
display a wide range of different migration modes and
morphologies (Box 1).
In vitro studies have identified several intrinsic factors
regulating migration mode and morphology. In cancer
cells migrating individually, increased contractility, un-
der control of the Rho-pathway, favors amoeboid-like
migration, while lower contractility (and/or increased
adhesion) favors more mesenchymal phenotypes [4–7].
Increased cell-cell interactions via cadherins and cell-
ECM binding via integrins can promote collective mi-
gration in cancer cells (reviewed in [3]). It is not currently
well understood how cell morphology affects a cell’s
ability or tendency to migrate individually or collective-
ly. However, cells with amoeboid-like morphologies
tend to migrate individually or in streams, while epithe-
lial cells migrate collectively. Cells with mesenchymal
morphologies can most readily switch between single-
cell, streaming and collective migration modes. For ex-
ample, in hepatocyte growth factor-treated MDCK cells,
which have a mesenchymal phenotype, upregulation of
N-cadherin activity can promote a switch from individual
to collective cell migration [8].
In addition to intrinsic factors, the microenvironment
plays a significant role in determining cancer cell migra-
tion mode and morphology. In the remainder of theCurrent Opinion in Cell Biology 2015, 36:13–22
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Summary of tumor progression and invasion. In tumors of epithelial origin, or carcinomas, hypertrophic cell growth causes the epithelial layer to
become many cell-layers thick. At more advanced stages, carcinoma cells often lose apical-basal polarity and apical cilia and may appear
disorganized, due to reduction in cell-cell contacts and cytoskeletal reorganization (see also Figure 2a; [28]). At this ‘carcinoma in situ’ stage, the
cancer cells are still encapsulated by the BM. Due to cross-talk between tumor cells and stromal cells, the stroma becomes reactive. Reactive
stroma is characterized by an increased presence of immune cells and fibroblasts, which can help to deposit ECM and reorganize the stromal
network (mostly made of collagen-I). Stromal network fibers are initially loosely organized and appear ‘curly’ and later increase in density and
stiffness. At late stages, collagen bundles form ‘tracks’ perpendicular to the BM. In invasive tumors, cancer cells perforate the BM or migrate
through regions of dysfunctional BM deposition, allowing the tumor cells to invade the stroma and migrate toward the blood stream (reviewed in
[2]). Stromal cells can also enter the tumor, leading to a mixing of cell types and further disorganization of the tissue.review, we will describe different migration modes that
have been observed in human pathology studies, intravi-
tal imaging studies and in vitro experiments and focus on
the role of the microenvironment in determining migra-
tion mode.
The pathology of tumor invasion in humans
In human epithelial cancers such as colorectal and breast
cancers, invasive cells are typically observed to migrate
collectively [15,16,17]. Invasive carcinomas often dis-
play a disorganized glandular structure (Figure 2a). From
these neoplastic glands, strands and cords of tumor cells
project into the stroma at the invasive front (Figure 2b–f;
[18–20]). Scattered clusters of 5 cells (tumor buds) have
also been observed (Figure 2b,c,f; [21,22]). This suggests
that invading tumor cells in vivo typically preserve cell-
cell contacts, leading to collective migration of groups of
cancer cells.
Invading cells often display characteristic Epithelial to
Mesenchymal Transition (EMT) markers, such as down-
regulation of E-cadherin and upregulation of Vimentin,
and lose some epithelial characteristics, such as apical-
basal polarity [23]. Despite these changes, in human
cancers, invading cells usually do not have a typicallyCurrent Opinion in Cell Biology 2015, 36:13–22 spindle-shaped mesenchymal phenotype. This has
fueled a debate over the role of EMT in human cancer
progression [15,20]. However, in pathological examina-
tions, it may be difficult to distinguish stromal cells from
individual tumor cells with spindle-shaped phenotypes,
potentially leading to the rarity of observed mesenchymal
tumor cells in human cancers. A recent study using 3D
reconstructions of serial tissue slices found that invading
tumor cells invade almost exclusively in a collective
manner. Cells in invading buds only rarely display
changes in morphology to spindle-shaped (mesenchymal)
or rounded phenotypes, while exhibiting some changes in
EMT markers [17].
Recent studies have uncovered that clusters of circulating
tumor cells (CTCs), also called tumor microemboli, are
present in the circulation of patients with invasive mela-
noma, lung cancer and renal cell carcinoma [24–26]. It
is possible that the presence of microemboli in the
circulation is due to intravasation of small groups of
collectively-migrating tumor cells. A recent study using
a mouse breast cancer model suggests that tumor cell
clusters in the circulation may indeed arise from the entry
of groups of tumor cells into vessels, rather than aggre-
gation of cancer cells following intravasation [27]. It iswww.sciencedirect.com
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Box 1 Cancer cell migration modes and dynamics
Single-cell migration is characterized by a lack of cell-cell
interactions during migration and low correlation in the migration
pattern between a cell and its neighbors. Cells that migrate singly
can display different phenotypes. In amoeboid-like migration, cells
have a round cell-body phenotype and can differ dramatically in their
protrusive activity. Amoeboid-like motility comes in several variants:
1) cells that rapidly change their morphology, have short thin
protrusions, are devoid of blebs and move with high velocities (0.4–
5 mm/min); 2) much slower cells with a blebbing morphology and
chaotic movements; 3) cells with short cellular protrusions asso-
ciated with proteolytic activity moving with low velocities (0.1 mm/
min). Other singly-migrating cells have a mesenchymal phenotype,
which is characterized by an elongated (‘spindle-shaped’) cell body
and longer protrusions. While the protrusions of such cells advance
relatively rapidly (0.4 mm/min, our unpublished data), in some
cases, the cell rear stays immobile, resulting in relatively slow net
translocation (0.2 mm/min).
Multicellular streaming is characterized by loosely- or non-
adherent cells that migrate along the same path. Cells in streams
have typical speeds of 1-2 mm/min and significantly longer and
straighter paths compared to isolated migratory cells and can
display amoeboid-like or mesenchymal phenotypes [3].
Collective migration is characterized by groups of cells that retain
cell-cell adhesions for long periods of time and display a high
correlation in directionality between neighboring cells during migra-
tion. Cells move either as narrow linear strands lead by one leader
cell or as broad, irregularly shaped sheets, which are multiple cells in
diameter and lead by several leader cells [3,9,10]. Collectively
migrating cells can display mesenchymal or epithelial phenotypes,
and the phenotypes may differ between ‘leader’ and ‘follower’ cells
in some cases [11]. Collective migration is typically the slowest mode
of cancer cell migration (0.01–0.05 mm/min), but faster collective
migration (0.2-1 mm/min) has been observed during development
in vivo (e.g., [12–14]).not currently clear if migration mode influences later
metastasis. However, the same study demonstrated that
such tumor cell clusters can more efficiently colonize
secondary organs [27].
Distant metastases typically recapitulate the epithelial/
glandular morphology of the primary tumor, with epithe-
lial-like phenotypes. This could suggest that metastases
arise from tumor cells with preserved epithelial charac-
teristics that migrate and colonize other organs as clusters.
Alternatively, individually-invading cells that have un-
dergone EMT could undergo a Mesenchymal to Epithelial
Transition (MET), upon reaching a secondary organ
[23,28,29]. Indeed, cells with mesenchymal phenotypes
are enriched in CTC populations in some breast and
colon cancer patients, and the presence of mesenchymal
CTCs correlates with poor prognosis [30,31].
During tumor progression, the stroma, which surrounds
the epithelial tissues, also undergoes profound changes.
The stroma is comprised primarily of a collagen-I net-
work. In normal stroma, collagen fibers typically appear
‘curly’ and anisotropic [32]. During early cancer progres-
sion, the amount of collagen in the stroma increases, andwww.sciencedirect.com collagen fibers appear straighter and are aligned parallel to
the tumor border [33]. Similar patterns have been found
using a murine breast cancer model [34]. In invasive
tumors, collagen fibers become bundled and are oriented
perpendicularly to the BM, providing ‘tracks’ for cancer
cells to migrate away from the primary tumor (Figure 1).
This particular organization of collagen is correlated with
poor patient survival [33].
The reorganization of the stromal network is primarily
mediated by stromal cells, most prominently fibroblasts.
Cancer-associated fibroblasts (CAFs) reorganize the stroma
by secreting ECM and enzymes that covalently cross-link
collagens fibers and by physically pulling on the collagen
network [32,35,36]. As a result, the stromal network
becomes stiffer. In breast cancers, neoplastic tissue can
be two- to ten-fold stiffer than normal tissue. This increase
in tissue stiffness is thought to primarily reflect changes in
the stroma [37–39], while tumor cells themselves appear to
become softer [40]. Breast tumors are more likely to develop
in regions of high tissue density [41], and tissue density
itself is a predictive risk factor in the development of breast
cancer [42–44]. The dramatic reorganization of the stroma
in invasive cancers is likely to contribute to changes in the
migratory properties of tumor cells that lead to later metas-
tasis [32]. Although many details of stromal evolution during
tumor progression are yet to be determined, an increase in
network stiffness and reorganization into thicker bundles
appears to correlate with an increased risk for metastasis.
Intravital imaging of cancer cell invasion
With the introduction of multiphoton-based intravital im-
aging about 15 years ago, it became possible to observe
cancer cell behavior during tumor invasion in vivo [45,46].
In intravital cancer cell migration experiments, tumors are
usually generated by subcutaneously or orthotopicaly
xenografting cancer cells that express fluorescent proteins.
Alternatively, cancer cell migration can be studied in
genetically modified animals that develop tumors sponta-
neously. Fluorescently-labeled dextran can be intravenous-
ly injected to highlight the vasculature, and stromal collagen
fibers can be visualized using second harmonic generation
(SHG). However, it is not currently possible to visualize
changes in the stromal network during tumor progression,
due to the relatively slow timescale of this process and
challenges in long-term imaging in intravital studies. New
tissue preparation methods may allow for the observation of
the co-evolution of stromal structure and tumor progression
on longer timescales. For excellent reviews on current
intravital imaging techniques, refer to [9,47,48].
While most studies agree that the vast majority of cancer
cells in vivo are immobile over periods of several hours, a
wide range of different migration modes and phenotypes
have been described for motile cancer cells (Table 1,
Figure 3). In general, grafted cells that display amoe-
boid-like morphology, such as A375 and B16F2 melanomaCurrent Opinion in Cell Biology 2015, 36:13–22
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Tumor invasion in human epithelial cancers. (a–c) Colon tissue section from colon cancer patient stained with a b-catenin antibody (brown). (a)
Section highlighting the difference in epithelial organization between normal glandular tissue (N) and a tumorous gland (T) separated by stroma (S).
(b) Colon cancer tissue section showing the edge of a tumorous gland (T), the invasive front (IF) and more distal stroma (S), which has not yet
been invaded. (c) Examples of invasion phenotypes from colon cancer tissue sections showing invasive gland structure (left, arrow), small tumor
buds that have separated from body of the tumor (left, arrowheads) and a cord of connected invasive cells (right). (d) Finger-like strands of
invading cancer cells in a singlet ring-type colon carcinoma, with b-catenin staining (brown). Modified from [83]. (e) Tissue section from breast
cancer patient showing a group of invasive cancer cells (C) surrounded by stroma (S). Cells are stained for the transcriptional regulator heat shock
factor 1 (HSF1; brown) and smooth muscle actin (SMA; pink). Modified from [84]. (f) Tissue section from an oral squamous cell carcinoma
displaying thin cords and strands of tumor cells as well as smaller tumor buds at the invasive front. Cells are stained for the nerve growth factor
receptor p75NTR (brown) and counterstained with hematoxylin (blue). Right: high-magnification zoom of outlined region in left image. Red arrows
indicate invasive cells expressing p75NTR. Modified from [85].cells, tend to migrate as single cells or as streams. Cells with
predominantly mesenchymal phenotypes, like MTLn3 or
HT-1080, are more prone to switching between single-cell
and collective migration modes. Intravital imaging has
been essential to building an understanding of tumor
cell invasion dynamics and how the native tumor environ-
ment can impact invasion and metastasis.
Intravital imaging studies suggest that the stromal colla-
gen network can significantly impact the mode and di-
rection of cancer cell migration. In breast cancer models,
while areas with low collagen density contain mostly non-
motile cells, motile cells can be found in the proximity of
large collagen bundles [55]. In fast-migrating cancer
cells, both with amoeboid-like and mesenchymal pheno-
types, cells orient their protrusions parallel to collagen
bundles, using the bundles as ‘highways’ for efficient,
directional migration [9,59,64]. Loosely connected
streams of migrating cells and collectively migrating cell
strands also align parallel to collagen fibers [9,61]. It has
recently been suggested that breast tumor cell behavior
(slow-moving and high ECM degradation vs. fast-moving
and invasive) is influenced by a combination of collagen
structure, presence of macrophages and proximity to
blood vessels [57].
The microenvironments of nearby tissues can also influ-
ence tumor cell migration. For example, melanoma cellsCurrent Opinion in Cell Biology 2015, 36:13–22 in the dermis tend to migrate as fast, directional and
collective strands along linear tracks of muscle fibers and
nerves. In contrast, cells migrating in fatty connective
tissue migrate slowly as a broad, poorly organized multi-
cellular group lead by several leader cells, from which
single cells occasionally detach [10]. Similarly for fibro-
sarcoma cells implanted in the deep dermis, loosely
organized fat tissue favors single-cell migration, while
muscle fibers and lymph vessels promote collective mi-
gration of multicellular strands [61]. These studies sug-
gest that more organized/aligned environments may
promote more collective migration.
The presence of nearby blood vessels can also influence
migration, though it is unclear if this is due to differences
in organization of the stromal network or signaling. Can-
cer cells are typically more motile in the proximity of
blood vessels; however, there is no correlation between
the occurrence of single-cell migration vs. streaming and
blood vessel density [54,58,65]. The presence of macro-
phages, which are usually found near blood vessels,
positively correlates with cancer cell motility [62]. It is
hypothesized that macrophages help cancer cells to in-
vade the stroma and to intravasate into blood vessels
[62,66,67].
In spontaneous murine colorectal tumors, distinct inva-
sive regions have been identified. In one region, thick andwww.sciencedirect.com
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Table 1
Migration modes and dynamics observed by intravital imaging.
Cell type Fraction of motile
cells
Migration mode Speed Reference
A375M2 human melanoma 70% amoeboid-like
(single-cell; with and without
blebs)
30% mesenchymal
0.5–10 mm/min
amoeboid-like: 3 mm/min
mesenchymal: 1 mm/min
[6]
A375 human melanoma 1–5% 55% amoeboid-like
(single cell; without blebs)
10% amoeboid-like
(single cell; with blebs)
35% mesenchymal
1–5 mm/min [49,50]
B16F2 mouse melanoma 6.6% (0–22% per
field of view)
56% single-cell (amoeboid-like)
44% multicellular streaming
0.4–6.7 mm/min
amoeboid: 1 mm/min
streaming: 2 mm/min
[51]
B16F2 mouse melanoma Most immobile Single-cell (amoeboid-like,
without blebs)
0.2–5 mm/min [52]
B16F10 mouse melanoma Collective (strands 3-5 cell
diameters)
0.25 mm/min [10]
MTLn3 rat breast cancer 1.6% mobile Single-cell [53]
MTLn3 rat breast cancer 10–20 cells per field 30% single-cell
70% multicellular streaming
Single-cell: 0.77 mm/min
streaming: 2.1 mm/min
[54]
MTLn3E rat breast cancer 1–5% (0–15% per
field of view)
30% single-cell
55% multicellular streaming
15% collective
Single-cell: 2.5 mm/min
streaming: 1 mm/min
[55,56]
MDA-MB-231
human
breast cancer
15% Single-cell (without blebs or
with invasive protrusions)
multicellular streaming
Single-cell (without blebs):
0.4–4.2 mm/min
single-cell (invasive
protrusions): 0.03–0.25 mm/min
[57]
MDA-MB-231
human
breast cancer
5%
(93% of fields have
1 motile cell)
44% single-cell
56% multicellular streaming
Single-cell: 0.7 mm/min
streaming: 1.2 mm/min
[58]
TN1 human breast cancer
(from effusion)
5%
(66% of fields have
1 motile cell)
44% single-cell
56% multicellular streaming
Single: 0.6 mm/min
streaming: 0.9 mm/min
[58]
CT26 mouse
colon carcinoma
Most immobile Single-cell (mesenchymal) 0.2 mm/min [59],
Unpublished
data
A431 human squamous cell
carcinoma
Single-cell (overexpression
of E-cadherin to switch to
collective)
[60]
HT-1080 human fibrosarcoma 90% 14% single-cell
86% collective
(sheets and strands)
[61]
Spontaneous mouse breast
tumors (MMTV-PyMT)
80%
(if close to
macrophage)
3.9 mm/min (in proximity
to macrophages; sig. slower
away from macrophages)
[62]
Spontaneous mouse intestine
tumors
(NICD; Trp53/;Villin-CreERT2)
Multicellular streaming
collective (sheets and strands)
occasional single-cell
[63],
Unpublished
datastraight collagen bundles containing stromal cells sur-
round collectively migrating sheets and strings of cancer
cells. In contrast, regions with poorly organized, shorter
and curly collagen fibers contain isolated cancer cells
[63]. This further supports the hypothesis that ECM
alignment may promote collective migration. However, in
these tumors, it is difficult to distinguish between the
effects of the microenvironment and genetic/signaling
differences, given the heterogeneity of these tumor cells.
In the case of xenografted tumors, which are usually
generated from established cell lines and thus genetically
similar, the range of different migration modes appears towww.sciencedirect.com be limited (see Box 1), indicating that these migration
modes are also heavily influenced by genetics and signal-
ing cues. For example, in murine breast cancer cells,
TGFb signaling can promote a transition from an immo-
bile epithelial-like state to individual amoeboid-like mi-
gration [56]. Future work will be required to address how
the combination of microenvironment structure, genetics
and signaling cues influences tumor cell migration modes
and dynamics.
Although intravital imaging accurately captures cancer
cell invasion in the native environment, such studiesCurrent Opinion in Cell Biology 2015, 36:13–22
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Modes of cancer cell migration in vivo. (a, a’) Two different areas in spontaneously growing murine intestinal tumors showing cell clusters and
independently migrating cells (a) and cells migrating collectively as strands and small clusters (a’). Green: tumor cells (nuclei). Pink: collagen (by
SHG). Blue: stromal cells (membrane). Modified from [63]. (b) Amoeboid-like migration of MTLn3 rat breast cancer cells in the mouse mammary
fat-pad. Green: cancer cells (myosin light chain). Red: collagen (SHG). Modified from [74]. (c, c’) Mesenchymal migration of mouse colon cancer
CT26 cells in the mouse dermis at successive time points. Green: cancer cells. Pink: collagen (SHG). Arrows and asterisks indicate the protrusion
tips for two different cells. Courtesy of Sara Geraldo. (d) Streaming migration of MTLn3 cells in the mouse mammary gland. Red: cancer cells
(photoconverted Dendra2). Green: cancer cells in the bulk of the tumor (non-photoconverted Dendra2). Modified from [54]. (e) Collective migration
of B16F10 mouse melanoma cells in the mouse dermis. Green: blood vessels. Red: collagen (SHG). Blue: cancer cells (nuclei). Yellow: cancer
cells (cytoplasm). Modified from [9].remain primarily descriptive, owing to the difficulty in
assaying and modifying properties of the tumor cells and
microenvironment. Due to limited resolution, most intra-
vital imaging setups cannot currently be used to study
sub-cellular activity. In contrast, in vitro studies offer a
more precise, controlled environment to test different
aspects of cancer cell migration at high resolution.
Tumor cell migration modes in vitro
A number of techniques have been developed to study cell
migration in 3D, in environments that closely resemble the
in vivo setting [68,69]. As the number of intravital imaging
studies has grown, it is becoming more apparent that the
timescale of single-cell migration in cancer cells, both in
vivo and in vitro, is mm/min, while collective migration
modes are typically slower (see Box 1). Networks for 3D
migration studies are typically comprised of ECM compo-
nents like collagen-I or matrigel, a dense network of
primarily collagen-IV and laminin [70]. Matrigel is moreCurrent Opinion in Cell Biology 2015, 36:13–22 similar in composition to the basement membrane than the
stroma and may not faithfully recapitulate the stromal
microenvironment [2,71]. The properties of collagen-I
networks (e.g., fiber thickness, pore size, mechanical prop-
erties) depend on the polymerization conditions and can
therefore be experimentally controlled [72].
The properties of collagen networks can influence 3D
cancer cell migration. Both migration velocity and the
requirement for proteolysis have been shown to depend
on pore size [72]. High network density and/or inhibition
of network degradation can promote contractility-depen-
dent amoeboid-like migration [4,73,74], though the abil-
ity of cancer cells to migrate without degradation may
depend on matrix cross-linking [75]. ECM network
properties can also affect collectivity during migration.
In a recent study, high collagen density was shown to
favor proteolytic-dependent collective migration in cul-
tured fibrosarcoma and melanoma cells, which displaywww.sciencedirect.com
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primary breast carcinomas (both human and the mouse
model MMTV-PyMT) are more likely to undergo col-
lective migration when embedded in collagen-I com-
pared with matrigel, which may reflect the differences in
structure and/or composition between collagen-I and
matrigel [77]. In collectively invading MMTV-PyMT
fragments in 3D, leader cells display a distinctly elongat-
ed, mesenchymal phenotype and remain in close contact
with follower cells [78].
Increased complexity in in vitro microenvironments will
help to further study the role of the stroma in cancer cell
invasion. Proteomics-based studies focused on determin-
ing the matrisome of different tissues (e.g. [79,80]) will help
to design more relevant in vitro systems. As the ECM
likely differs significantly between different cancer types,
in vitro systems should be adapted to recapitulate the
native stromal environment. In their microenvironment,
tumor cells also interact with other tumor and stromal
cells. Experimental systems combining cancer cells and
stromal cells will help to understand the importance of
heterologous cell-cell interactions during invasion and
metastasis.
Conclusions and outlook
Pathology, intravital and in vitro studies point to a dy-
namic regulation of cell migration in tumor cells. How-
ever, it is unclear why human epithelial cancer cells
predominantly migrate collectively, while most cells ob-
served in vivo using intravital techniques and in vitro
studies migrate as single cells. One potential explanation
for this discrepancy is the difference in the stromal
environment. In human cancers, the tumor and stroma
evolve together over months and years. In most intravital
imaging studies, where tumor cells are implanted, the
stroma has not had sufficient time to progress, either in
terms of structure or stromal cell population. In addition,
many intravital imaging studies use Nude mice to allow
for the growth of xenografted tumor tissue; the lack of a
sufficient immune response could affect stromal network
remodeling or the chemical signals in the tumor environ-
ment, which could bias migration mode and morphology.
Alternatively, human and mouse stroma may differ sig-
nificantly enough to change the pattern of cancer cell
invasion. To account for some of these potential sources
of bias, mouse models that form spontaneous tumors may
be a good alternative to grafting cancer cells in mice.
These models allow for the co-evolution of the tumor and
stroma in non-immunodeficient mice, providing a more
realistic microenvironment for cancer cell migration as
well as a heterogeneous population of tumor cells that
more closely reflects the disease state. New genome-
editing techniques such as CRIPR/Cas9 will allow for
more flexibility in labeling and genetically modifying
tumor and stromal cells to test mechanisms of migration
and metastasis in intravital studies.www.sciencedirect.com Another challenge for the future of cancer cell migration
research will be to more directly relate findings from
intravital imaging studies to human cancer. Several stud-
ies have already related findings from intravital studies to
human disease. For example, specific alignment of colla-
gen fibers, termed tumor-associated collagen signature
(TACS), has been identified as an independent prognos-
tic factor for breast cancer patients [33]. Similarly, cel-
lular arrangements composed of a carcinoma cell, a
macrophage, and an endothelial cell, termed tumor mi-
croenvironment of metastasis (TMEM), are suggested to
serve as an independent indicator for metastasis develop-
ment [81]. Higher density of TMEM correlates with a
greater chance that a patient will develop distant metas-
tasis. These and similar studies could allow for the
development of treatments to prevent metastasis targeted
toward the microenvironment rather than tumor cells
themselves.
Cancer cell invasion is a flexible and multi-factorial
process. How does the combination of stromal network
structure, genetics and signaling cues determine how
cancer cells migrate? How might migration mode influ-
ence cancer progression? Is collective migration a more
efficient route to metastasis? Cells migrating collectively
could have improved chemokine sensing through leader
exchange or multicellular signal integration, as recently
shown in 2D [82], allowing them to more efficiently reach
the circulation by following chemical cues. Alternatively,
collective migration could allow for a greater diversity in
tumor cells seeding other organs. More migratory cancer
cells could ‘pull’ cancer stem cells through the stroma and
secondary organs, allowing the cancer stem cells to nest
and proliferate at metastatic sites. Groups of cancer cells
could also be more resistant to attack by the immune
system or mechanical stress. Work toward addressing
these questions will help not only to understand the basic
cell biology of cell migration, but will also help to under-
stand the escape mechanisms cancer cells use to metas-
tasize to distant organs.
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